KIT and intrahepatic cholangiocarcinoma: Moreover, in a majority of patients (5 out of 7) 11.7±1.2% of the cells identified by ICC and 19.1±1.2% of the cells identified by flow cytometry (n = 3 patients, data not shown) were KDR+ before c-kit MACS (Figure 8C.f.